Your SlideShare is downloading. ×
Pharmaceuticals market in china   market brief
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pharmaceuticals market in china market brief

404

Published on

Published in: Business, News & Politics
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
404
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. PHARMACEUTICALS MARKET IN CHINA Market Brief Beijing Zeefer Consulting Ltd. October 2011
  • 2. Authorized by:Beijing Zeefer Consulting Ltd.Company Site:http://www.Zeefer.orgOnline Store of China Industry Reports:http://www.AllChinaReports.comBeijing Zeefer Consulting Ltd. and (or) its affiliates (hereafter,"Zeefer") provide this publication with the greatest possible care.Nevertheless, Zeefer makes no guarantee whatsoever regarding theaccuracy, utility, or certainty of the information in this publication.Further, Zeefer disclaims any and all responsibility for damages thatmay result from the use or non-use of the information in thispublication.The information in this publication may be incomplete and/or maydiffer in expression from other information in elsewhere by othermeans. The information contained in this publication may also bechanged or removed without prior notice.
  • 3. About Zeefer ConsultingBeijing Zeefer Consulting Ltd. is a professional consulting firm focusing on providing Chinamarket research, China market entry strategy and industrial intelligence information services.ZEEFER was founded in 2002, located in Beijing, China.ZEEFER’s research service includes: CHINA MARKET ENTRY RESEARCHIt is market entry guidance for target products, providing essential China market information,assisting clients to enter China market and expand market share in China. This researchservice extensively covers main industry products and consumer products. CUSTOMIZED MARKET RESEARCHProviding on demand market research service, it is focusing on assisting clients to solve theindividual issues when they are interested in China market. Usually the research contentscovering product viability, competition analysis, market size, sales channel, administrationissues, market trends, industry policies, market entry issues, etc. CHINA IMPORTED AND EXPORTED COMMODITIES RESEARCHProviding import and export data analysis for target products, a direct view to describe importand export trend by plenty figures and tables. Contrasting the trade data in different countries,origins, destinations and trade modes. To discover the fact and reason behind the trendchanges. FINDING CHINESE PARTNERSTo assist clients in finding the right potential partners, connecting clients with potential buyers,distributors, agents, importers and exporters, administrative organizations and competitors inChina. CHINA INDUSTRY PROFILES500+ yearly updated industry profiles on 500+ Chinese industries. The profiles presentoverview for each of these industries by providing concise analyses and 3 years key data.These profiles reflect the position of foreign enterprises and show the regional differencesacross China in each of the industries. CHINA MARKET REPORTSThis series includes more than 200 market research reports on over 200 market sectors inChina. Contents of these reports consist of market size, market share & structure, hotdomestic regions, top 10 enterprises, import & export, key statistical data and industrystandards. All the market reports are yearly updated.For more information please visit:Company Site: www.Zeefer.orgChina Industry Reports: www.AllChinaReports.com
  • 4. TABLE OF CONTENTPharmaceutical & Medicine Market in China....................................................................1Chinese Prepared Medicines Market in China ...................................................................4Pharmaceutical Raw Materials Market in China...............................................................7Medical Materials & Supplies Market in China...............................................................10
  • 5. www.AllChinaReports.com Industry Reports & Market ResearchPHARMACEUTICAL & MEDICINE MARKET IN CHINAChina pharmaceutical & medicine market size exceeded RMB 250 billionin 2009, a growth of more than 20% on a year-on-year basis, according toZeefer Consultings research report - China Pharmaceutical & MedicineMarket Report.In terms of market position of foreign enterprises in China, in 2009, therewere more than 250 foreign enterprises above designated size engaged inthe pharmaceutical & medicine industry, accounting for more than 20% ofall pharmaceutical & medicine enterprises above designated size acrossChina. All foreign pharmaceutical & medicine enterprises achieved aprofit of more than RMB 10 billion in all, accounting for more than 45% ofthe total profit in this industry.In terms of the industry size, in 2009, enterprises above designated sizeinside the pharmaceutical & medicine industry achieved a sales revenueof more than RMB 200 billion in all. In the pharmaceutical & medicineindustry, more than 1,000 enterprises were above designated size, anincrease of more than 5% on a year-on-year basis. On an annual average,employees in pharmaceutical & medicine industry were more than425,000, an increase of more than 4% on a year-on-year basis.In terms of industry profit, in 2009, enterprises above designated size inpharmaceutical & medicine industry across China achieved a profit ofmore than RMB 25 billion in all, a growth of more than 20% on ayear-on-year basis. In 2009, more than 250 enterprises in this industrysuffered a loss. The industry average of the rate of return on assets wasBeijing Zeefer Consulting Ltd. -1-
  • 6. www.AllChinaReports.com Industry Reports & Market Researchhigher than 10%, and the rate of return on net assets was higher than 15%.In terms of pharmaceutical & medicine import and export, in 2010, thevalue of imported pharmaceutical & medicine products in China wasmore than USD 5 billion, and Germany, Italy and USA ranked top 3 asOrigin of Imported Goods, imports from these top three origins added upto USD 2.1 billion, accounting for more than 35% of the gross imports.Shanghai, Beijing and Jiangsu ranked top 3 domestic destinations inimports, and the value of imports in these three regions added up to USD3.1 billion, accounting for more than 55% of the gross imports acrossChina. In 2010, the gross export of pharmaceutical & medicine productsexceeded USD 900 million, Jiangsu, Shanghai and Hebei ranked top 3 asdomestic origins, exports from these origins added up to USD 435.2million, accounting for more than 45% of the gross export across China.In terms of the market share in China, top 10 leading enterprises inpharmaceutical & medicine industry won a market share of more than25% in all in terms of the sales revenue, and the top leading enterprisegained a market share of more than 7% (source: data for 2008). In terms ofthe market position of imported pharmaceutical & medicine products, in2009, imported products won a market share of higher than 11% in thepharmaceutical & medicine market across China.Data Source:China Pharmaceutical & Medicine Market ReportRelated Industry Reports:China Pharmaceutical Mfg. Industry ProfileChina Pharmaceutical & Medicine Mfg. Industry ProfileChina Pharmaceuticals Industry ProfileTop Five Companies In Pharmaceutical & Medicine Mfg. Industry In ChinaBeijing Zeefer Consulting Ltd. -2-
  • 7. www.AllChinaReports.com Industry Reports & Market Research中国医薬品製剤製造業界レポート中国医薬品製造業界レポートBeijing Zeefer Consulting Ltd. -3-
  • 8. www.AllChinaReports.com Industry Reports & Market ResearchCHINESE PREPARED MEDICINES MARKET IN CHINAAccording to Zeefer Consultings research report - China ChinesePrepared Medicines Market Report and calculated according to ZeeferChina Market Size formula, China chinese prepared medicines marketsize in 2009 exceeded RMB 150 billion, a growth of more than 20% on ayear-on-year basis.In terms of market position of foreign enterprises in China, in 2009, therewere more than 200 foreign enterprises above designated size engaged inthe chinese prepared medicines industry, accounting for more than 10%of all chinese prepared medicines enterprises above designated sizeacross China. These enterprises achieved a sales revenue of more thanRMB 20 billion in all, accounting for more than 10% of the total salesrevenue from all chinese prepared medicines enterprises abovedesignated size across China.In terms of the industry size, in 2009, enterprises above designated sizeinside the chinese prepared medicines industry achieved a sales revenueof more than RMB 150 billion in all. They produced a total of more than1,445,000 tons of chinese patent medicine, a rise of more than 10% in totalproduction on a year-on-year basis. The total assets of all enterprises inthe industry exceeded RMB 200 billion, a rise of more than 10% on ayear-on-year basis. On an annual average, employees in chinese preparedmedicines industry were more than 380,000, an increase of more than 5%on a year-on-year basis.In terms of industry profit, in 2009, enterprises above designated size inBeijing Zeefer Consulting Ltd. -4-
  • 9. www.AllChinaReports.com Industry Reports & Market Researchchinese prepared medicines industry across China achieved a profit ofmore than RMB 15 billion in all, a growth of more than 20% on ayear-on-year basis. On average, enterprises achieved a profit margin ofmore than 10%. The industry average of the rate of return on assets washigher than 7%, and the rate of return on net assets was higher than 10%.In terms of chinese prepared medicines import and export, in 2010, thevalue of imported chinese prepared medicines products in China wasmore than USD 200 million, and Hong Kong, Germany and Japan rankedtop 3 as Origin of Imported Goods, imports from these top three originsadded up to USD 210.1 million, accounting for more than 95% of the grossimports. Guangdong, Shanghai and Beijing ranked top 3 domesticdestinations in imports, and the value of imports in these three regionsadded up to USD 211.4 million, accounting for more than 95% of the grossimports across China. In 2010, the gross export of chinese preparedmedicines products exceeded USD 200 million, and Hong Kong, Japanand India ranked top 3 as export destinations. Exports to thesedestinations added up to USD 112.3 million, accounting for more than40% of the gross export.In terms of the market share in China, top 10 leading enterprises inchinese prepared medicines industry won a market share of more than20% in all in terms of the sales revenue, and the top leading enterprisegained a market share of more than 5% (source: data for 2008). In terms ofthe market position of imported chinese prepared medicines products, in2009, imported products won a market share of 0.7% in the chineseprepared medicines market across China.Data Source:China Chinese Prepared Medicines Market ReportBeijing Zeefer Consulting Ltd. -5-
  • 10. www.AllChinaReports.com Industry Reports & Market ResearchRelated Industry Reports:China Pharmaceutical Mfg. Industry ProfileChina Chinese Prepared Medicines Mfg. Industry ProfileChina Pharmaceuticals Industry Profile中国漢方製剤製造業界レポート中国医薬品製造業界レポートBeijing Zeefer Consulting Ltd. -6-
  • 11. www.AllChinaReports.com Industry Reports & Market Research PHARMACEUTICAL RAW MATERIALS MARKET IN CHINAAccording to Zeefer Consultings research report - China PharmaceuticalRaw Materials Market Report and calculated according to Zeefer ChinaMarket Size formula, China pharmaceutical raw materials market size in2009 exceeded RMB 150 billion, a growth of more than 15% on ayear-on-year basis.In terms of market position of foreign enterprises in China, in 2009, therewere more than 200 foreign enterprises above designated size engaged inthe pharmaceutical raw materials industry, accounting for more than 15%of all pharmaceutical raw materials enterprises above designated sizeacross China. These enterprises achieved a sales revenue of more thanRMB 45 billion in all, accounting for more than 25% of the total salesrevenue from all pharmaceutical raw materials enterprises abovedesignated size across China. Foreign pharmaceutical raw materialsenterprises achieved a profit margin of more than 9%, higher than theindustry average, and they achieved a ratio of return on assets of morethan 9%, higher than the industry average.In terms of the industry size, in 2009, enterprises above designated sizeinside the pharmaceutical raw materials industry achieved a salesrevenue of more than RMB 150 billion in all. They produced a total ofmore than 1,690,000 tons of pharmaceutical raw materials, almost same intotal production on a year-on-year basis. The total assets of all enterprisesin the industry exceeded RMB 150 billion, a rise of more than 6% on ayear-on-year basis. On an annual average, employees in pharmaceuticalraw materials industry were more than 305,000, an increase of more thanBeijing Zeefer Consulting Ltd. -7-
  • 12. www.AllChinaReports.com Industry Reports & Market Research3% on a year-on-year basis.In terms of industry profit, in 2009, enterprises above designated size inpharmaceutical raw materials industry across China achieved a profit ofmore than RMB 10 billion in all, a growth of more than 10% on ayear-on-year basis. On average, enterprises achieved a profit margin ofmore than 8%. In 2009, more than 150 enterprises in this industry suffereda loss. and the loss from them added up to RMB 804.1 million.In terms of pharmaceutical raw materials import and export, in 2010, thevalue of imported pharmaceutical raw materials products in China wasmore than USD 1 billion, and Norway, Ireland and Japan ranked top 3 asOrigin of Imported Goods, imports from these top three origins added upto USD 711.8 million, accounting for more than 35% of the gross imports.In 2010, the gross export of pharmaceutical raw materials productsexceeded USD 10 billion, and India, USA and Germany ranked top 3 asexport destinations. Exports to these destinations added up to USD 4.4billion, accounting for more than 35% of the gross export. Zhejiang,Jiangsu and Shandong ranked top 3 as domestic origins, exports fromthese origins added up to USD 5.5 billion, accounting for more than 45%of the gross export across China.In terms of the market share in China, top 10 leading enterprises inpharmaceutical raw materials industry won a market share of more than20% in all in terms of the sales revenue, and the top leading enterprisegained a market share of more than 6% (source: data for 2008). In terms ofthe market position of imported pharmaceutical raw materials products,in 2009, imported products won a market share of less than 8% in thepharmaceutical raw materials market across China.Data Source:Beijing Zeefer Consulting Ltd. -8-
  • 13. www.AllChinaReports.com Industry Reports & Market ResearchChina Pharmaceutical Raw Materials Market ReportRelated Industry Reports:China Pharmaceutical Mfg. Industry ProfileChina Pharmaceutical Raw Materials Mfg. Industry ProfileChina Pharmaceuticals Industry Profile中国医薬品原薬製造業界レポート中国医薬品製造業界レポートBeijing Zeefer Consulting Ltd. -9-
  • 14. www.AllChinaReports.com Industry Reports & Market Research MEDICAL MATERIALS & SUPPLIES MARKET IN CHINAAccording to Zeefer Consultings research report - China MedicalMaterials & Supplies Market Report and calculated according to ZeeferChina Market Size formula, China medical materials & supplies marketsize in 2009 exceeded RMB 45 billion, a growth of more than 35% on ayear-on-year basis.In terms of market position of foreign enterprises in China, in 2009, therewere more than 100 foreign enterprises above designated size engaged inthe medical materials & supplies industry, accounting for more than 20%of all medical materials & supplies enterprises above designated sizeacross China. These enterprises achieved a sales revenue of more thanRMB 10 billion in all, accounting for more than 20% of the total salesrevenue from all medical materials & supplies enterprises abovedesignated size across China. Foreign medical materials & suppliesenterprises achieved a profit margin of more than 7%, almost same withthe industry average, and they achieved a ratio of return on assets of morethan 8%, lower than the industry average.In terms of the industry size, in 2009, enterprises above designated sizeinside the medical materials & supplies industry achieved a sales revenueof more than RMB 45 billion in all. The total assets of all enterprises in theindustry exceeded RMB 35 billion, a rise of more than 30% on ayear-on-year basis. On an annual average, employees in medical materials& supplies industry were more than 115,000, an increase of more than10% on a year-on-year basis.Beijing Zeefer Consulting Ltd. - 10 -
  • 15. www.AllChinaReports.com Industry Reports & Market ResearchIn terms of industry profit, in 2009, enterprises above designated size inmedical materials & supplies industry across China achieved a profit ofmore than RMB 3 billion in all, a growth of more than 40% on ayear-on-year basis. On average, enterprises achieved a profit margin ofmore than 8%. The industry average of the rate of return on assets washigher than 10%, and the rate of return on net assets was higher than 15%.In terms of medical materials & supplies import and export, in 2010, thevalue of imported medical materials & supplies products in China wasmore than USD 600 million, and USA, Netherlands and Japan ranked top3 as Origin of Imported Goods, imports from these top three originsadded up to USD 317 million, accounting for more than 45% of the grossimports. In 2010, the gross export of medical materials & suppliesproducts exceeded USD 1 billion, and USA, Japan and Germany rankedtop 3 as export destinations. Exports to these destinations added up toUSD 585 million, accounting for more than 35% of the gross export.Jiangsu, Zhejiang and Hubei ranked top 3 as domestic origins, exportsfrom these origins added up to USD 770.7 million, accounting for morethan 45% of the gross export across China.In terms of the market share in China, top 10 leading enterprises inmedical materials & supplies industry won a market share of more than25% in all in terms of the sales revenue, and the top leading enterprisegained a market share of more than 10% (source: data for 2008). In termsof the market position of imported medical materials & supplies products,in 2009, imported products won a market share of less than 7% in themedical materials & supplies market across China.Data Source:China Medical Materials & Supplies Market ReportBeijing Zeefer Consulting Ltd. - 11 -
  • 16. www.AllChinaReports.com Industry Reports & Market ResearchRelated Industry Reports:China Pharmaceutical Mfg. Industry ProfileChina Medical Materials & Supplies Mfg. Industry ProfileChina Pharmaceuticals Industry ProfileChina Other Manufacturing Industry ProfileTop Ten Companies In Medical Materials & Supplies Mfg. Industry In China中国医療衛生用品製造業界レポート中国医薬品製造業界レポートBeijing Zeefer Consulting Ltd. - 12 -
  • 17. Zeefer Publications China Market Report Research Reports on Major Industries in China Publication Date: July 1, 2012 ISBN: 978-0-473-19979-1 Format: Paperback / PDF Pages: 500+ Paperback / 1200+ PDF List Price: US$599 The Series Of Approaching China Publication Date: November 30, 2010 Format: Paperback; List Price: US$129 per title ·Confectionery Market·Beverage Market·Meat Market ·Fruit Industry·Grain & Oil Industries·Dairy Market ·Natural Rubber Market·Apparel Market ·Aquatic Products Market·Medical Industries China Economy Atlas Data Maps for 133 Major Chinese Industries Publication Date: November 20, 2011 ISBN: 978-0-473-19978-4 Format: Paperback / PDF Pages: 268 List Price: FREE for PDF Version Get it now! China Market Brief Brief Introduction on 193 Market Sectors Publication Date: November 10, 2011 Format: PDF Pages: 542 Word Count: 116,126 List Price: FREE Get it now!

×